DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced it would report its financial results for the second quarter of 2011 on Wednesday, July 27, 2011 after market close. The announcement will be followed by a conference call with the investment community the following day, Thursday, July 28 at 8:30 am ET.
